Greenland Mines(NASDAQ) GRML

Market Cap$10.36M

Since IPO (2022)-99%

5 YearN/A

1 Year-89%

1 Month-68%

$3.11

-4.60%

-0.15Today

After hours$3.13+$0.02 (+0.64%)

Greenland Mines last closing stock price
Metric	Price	Date
Last close	USD 3.26	2026-09-14

Greenland Mines stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-31.51%	USD 4.76	2026-09-04
1 month	-67.93%	USD 10.17	2026-08-14
3 month	-79.82%	USD 16.16	2026-06-16
Year to date	-77.44%	USD 14.45	2025-12-31
1 year	-88.95%	USD 29.51	2025-09-12
3 year	-99.39%	USD 532.50	2023-09-15
Since inception	-99.34%	USD 494.50	2022-04-29

Greenland Mines Financials at a Glance

Market Cap

$10.36M

Revenue (TTM)

$0.00

Net Income (TTM)

-$21.77M

EPS (TTM)

-$12.20

P/E Ratio

-0.27

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Price

$3.11

Volume

372,898

Open

$3.25

Price

$3.11

Volume

372,898

Open

$3.25

Previous Close

$3.11

Daily Range

$3.07 - $3.26

52-Week Range

$2.99 - $36.99

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Price

$3.11

Volume

372,898

Open

$3.25

Previous Close

$3.11

Daily Range

$3.07 - $3.26

52-Week Range

$2.99 - $36.99

Estimated Earnings Date

N/A

GRML News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Greenland Mines

Anew Medical, Inc. is a biopharmaceutical firm focused on developing innovative treatments for neurological conditions and age-related illnesses. The company is advancing cell and gene therapies aimed at alleviating symptoms of dementia, Alzheimer's disease, and other neuromuscular disorders.

Products and Services

Advanced cell and gene therapies for age-related conditions
Biologics and biosimilars for cancer treatment
Specialized diagnostic tools for neurological disorders

Growth Outlook

Strategic alliance with Okinawa Research Center enhances research capabilities
Focus on Klotho gene therapy aims to extend human longevity
Growing demand for innovative treatments in the aging population

Financial Highlights

Recent quarterly net income of -$451,639 reflects ongoing investment in R&D
Trailing twelve months (TTM) P/E ratio of 5.19 indicates potential value
Cash and short-term investments increased to $845,336 in Q2 2024

Anew Medical, Inc. is positioned in the biotechnology sector, with a strong emphasis on addressing significant health challenges associated with aging. The company's innovative pipeline and strategic partnerships suggest a commitment to advancing healthcare solutions. Recent financial data indicates a focus on research and development, which may lead to future growth opportunities. The current P/E ratio suggests that the stock may be undervalued compared to industry peers, while the increase in cash reserves highlights a strengthening financial position. Overall, Anew Medical represents a compelling opportunity for investors interested in the biotechnology field.

AI Generated • Aug 21, 2026

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Joseph Sinkule, PharmD

Website

greenlandmines.com

Headquarters

Charlotte, NE 28203, US

GRML Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-67.62%

Return on Capital

-75.51%

Return on Assets

-33.48%

Earnings Yield

-3.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.36M

Shares Outstanding

3.18M

Volume

372.90K

Avg. Volume

338.47K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$18.67M

EBITDA

-$23.01M

Operating Cash Flow

-$13.90M

Capital Expenditure

-$682.85K

Free Cash Flow

-$14.58M

Cash & ST Invst.

$9.34M

Total Debt

$297.97K

Greenland Mines Performance Analysis

Greenland Mines annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Greenland Mines sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A
Q2	2026-06-30	N/A

Greenland Mines annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD 4.14	N/A
2023	2023-12-31	USD -2.34	N/A
2024	2024-12-31	USD -15.98	583.4%
2025	2025-12-31	USD -10.88	-31.9%

Greenland Mines sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	59.5%
Q4	2025-12-31	62.6%
Q1	2026-03-31	-724.2%
Q2	2026-06-30	80.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$10.36M

N/A

Market Cap/Employee

$2.07M

N/A

Employees

N/A

Net Income

-$3.69M

+10.0%

EBITDA

-$5.49M

-190.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$9.34M

+10.8%

Total Debt

$297.97K

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$297.97K

N/A

Return on Assets

-33.48%

N/A

Return on Invested Capital

-29.26%

N/A

Free Cash Flow

-$6.88M

-249.4%

Operating Cash Flow

-$6.56M

-233.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,587.01-0.00%

^DJIDJI

^DJIDJI$52,024.29-0.01%

^IXICNASDAQ

^IXICNASDAQ$25,994.03-0.01%

BTCBitcoin

BTCBitcoin$76,604.00-0.03%

SPCXSPCX

SPCXSPCX$144.24-0.03%

AAPLAAPL

AAPLAAPL$330.57-0.01%

AMZNAMZN

AMZNAMZN$248.67-0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

VEEAVeea

VEEAVeea$5.71+149.34%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.23-3.58%

NVDANvidia

NVDANvidia$212.17+0.57%

INTCIntel

INTCIntel$97.14-0.05%

NOKNokia

NOKNokia$9.84+1.97%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.77-2.52%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.11-3.64%

Questions About GRML

What is the current price of Greenland Mines?

Greenland Mines is trading at $3.11 per share.

What is the 52-week range for Greenland Mines?

Over the past 52 weeks, Greenland Mines has traded between $2.99 and $36.99.

How much debt does Greenland Mines have?

As of the most recent reporting period, Greenland Mines reported total debt of $297.97K.

How much cash does Greenland Mines have on hand?

Greenland Mines reported $9.34M in cash and cash equivalents in its most recent financial results.

What is Greenland Mines’s dividend yield?

Greenland Mines does not currently have a dividend yield.

Greenland Mines(NASDAQ) GRML

Greenland Mines Financials at a Glance

GRML News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Greenland Mines

GRML Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Greenland Mines Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GRML

What is the current price of Greenland Mines?

What is the 52-week range for Greenland Mines?

How much debt does Greenland Mines have?

How much cash does Greenland Mines have on hand?

What is Greenland Mines’s dividend yield?

Premium Investing Services